Genomic Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the genomic deals entered into by the world's leading biopharma companies.
Fully revised and updated, the report provides details of genomic deals from 2018 to 2025.
The report provides a detailed understanding and analysis of how and why companies enter genomic deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
The report includes collaboration, development, research and licensing deals.
This report contains a comprehensive listing of 639 genomic deals announced since 2018 including financial terms where available including links to online deal records of actual genomic partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.
The initial chapters of this report provide an orientation of genomic dealmaking.
Chapter 1 provides an introduction to the report.
Chapter 2 provides an overview of the trends in genomic dealmaking since 2018.
Chapter 3 provides an overview of the leading genomic deals since 2018. Deals are listed by headline value.
Chapter 4 provides a comprehensive listing of the top 25 most active companies in genomic dealmaking with a brief summary followed by a comprehensive listing of genomic deals, as well as contract documents available in the public domain.
Chapter 5 provides a comprehensive and detailed review of genomic deals signed and announced since Jan 2018, where a contract document is available in the public domain.
Chapter 6 provides a comprehensive and detailed review of genomic partnering deals signed and announced since Jan 2018. The chapter is organized by specific genomic technology type in focus.
The report also includes numerous table and figures that illustrate the trends and activities in genomic deal making since 2018.
In addition, a comprehensive deal directory is provided organized by company A-Z, deal type and therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Fully revised and updated, the report provides details of genomic deals from 2018 to 2025.
The report provides a detailed understanding and analysis of how and why companies enter genomic deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
The report includes collaboration, development, research and licensing deals.
This report contains a comprehensive listing of 639 genomic deals announced since 2018 including financial terms where available including links to online deal records of actual genomic partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.
The initial chapters of this report provide an orientation of genomic dealmaking.
Chapter 1 provides an introduction to the report.
Chapter 2 provides an overview of the trends in genomic dealmaking since 2018.
Chapter 3 provides an overview of the leading genomic deals since 2018. Deals are listed by headline value.
Chapter 4 provides a comprehensive listing of the top 25 most active companies in genomic dealmaking with a brief summary followed by a comprehensive listing of genomic deals, as well as contract documents available in the public domain.
Chapter 5 provides a comprehensive and detailed review of genomic deals signed and announced since Jan 2018, where a contract document is available in the public domain.
Chapter 6 provides a comprehensive and detailed review of genomic partnering deals signed and announced since Jan 2018. The chapter is organized by specific genomic technology type in focus.
The report also includes numerous table and figures that illustrate the trends and activities in genomic deal making since 2018.
In addition, a comprehensive deal directory is provided organized by company A-Z, deal type and therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Genomic Collaboration and Licensing Deals provides the reader with the following key benefits:
- Understand deal trends since 2018
- Browse genomic collaboration and licensing deals
- Benchmark analysis - identify market value of transactions
- Financials terms - upfront, milestone, royalties
- Directory of deals by company A-Z, deal type and therapy area
- Leading deals by value
- Most active dealmakers
- Identify assets and deal terms for each transaction
- Access contract documents - insights into deal structures
- Due diligence - assess suitability of your proposed deal terms for partner companies
- Save hundreds of hours of research time
Report Scope
Genomic Collaboration and Licensing Deals is intended to provide the reader with an in-depth understanding of genomic trends and structure of deals entered into by leading biopharma companies worldwide.Genomic Collaboration and Licensing Deals includes:
- Trends in genomic dealmaking in the biopharma industry
- Directory of genomic deal records covering pharmaceutical and biotechnology
- The leading genomic deals by value
- Most active genomic licensing dealmakers
Analyzing contract agreements allows due diligence of:
- What are the precise rights granted or optioned?
- What is actually granted by the agreement to the partner company?
- What exclusivity is granted?
- What is the payment structure for the deal?
- How are sales and payments audited?
- What is the deal term?
- How are the key terms of the agreement defined?
- How are IPRs handled and owned?
- Who is responsible for commercialization?
- Who is responsible for development, supply, and manufacture?
- How is confidentiality and publication managed?
- How are disputes to be resolved?
- Under what conditions can the deal be terminated?
- What happens when there is a change of ownership?
- What sublicensing and subcontracting provisions have been agreed?
- Which boilerplate clauses does the company insist upon?
- Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
- Which jurisdiction does the company insist upon for agreement law?
Table of Contents
Executive SummaryChapter 1 - IntroductionChapter 6 - Genomic dealmaking by technology type
Chapter 2 - Trends in genomic dealmaking
Chapter 3 - Leading genomic deals
Chapter 4 - Most active genomic dealmakers
Chapter 5 - Genomic contracts dealmaking directory
Deal directory
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 1CellBiO
- 2bPrecise
- 2seventy bio
- 4baseCare
- 4bases
- 4D Molecular Therapeutics
- 4P-Pharma
- 10X Genomics
- 22nd Century
- 23andMe
- 221b Foundation
- A*STAR Bioinformatics Institute
- Abbvie
- AbCellera Biologics
- Abiosciences
- ABL Diagnostics
- Accelerated Biosciences
- Accelerated Cure Project for MS
- Accelerate Technologies
- Accenture
- AccessDx Laboratory
- Access to Comprehensive Genomic Profiling Coalition
- AccuGenomics
- AccuStem Sciences
- AcelaBio
- Acerta Pharma
- Acrobat Genomics
- Active Motif
- Acuitas Therapeutics
- Adapsyn Bioscience
- Adaptimmune
- Adaptive Biotechnologies
- Adicet Bio
- Adrestia
- Advanced Biological Innovation and Manufacturing
- Advanced Biological Laboratories
- Aelian Biotechnology
- Affini-T Therapeutics
- AgBiome
- Agena Bioscience
- Agendia
- Agilent Technologies
- Agribody Technologies
- Agriplex Genomics
- AiLife Diagnostics
- Akadeum Life Sciences
- Akoya Biosciences
- ALBOT Technologies
- Aldevron
- Alexion Pharmaceuticals
- Algen Biotechnologies
- AlgenScribe
- Alida Biosciences
- Alimentiv
- Allarity Therapeutics
- Allele Biotechnology and Pharmaceuticals
- Allelica
- Allogene Therapeutics
- Alloy Therapeutics
- Allscripts
- Almac Diagnostics
- Almaden Genomics
- Alnylam Pharmaceuticals
- Amazon Web Services
- Ambry Genetics
- American Medical Association
- American Skin Association
- American Society of Hematology
- Amfora
- Amgen
- Amoy Diagnostics
- Analytical BioSciences
- Ancestry
- AnchorDx
- Ankarys Therapeutics
- Anocca AB
- Apollomics
- Applied Biological Materials
- Applied Biosystems
- Applied Cells
- Applied StemCell
- APST Research
- Aptorum Group
- Arbor Biotechnologies
- Arbutus
- ArcherDX
- ARCHIMEDlife
- Arctoris
- Ares Genetics
- Arima Genomics
- Artisan Bio
- Asa Ren
- ASC Therapeutics
- Asklepios Biopharmaceutical
- Assistance Publique-Hôpitaux de Paris
- Associazione Poic e Dintorni APS
- Astellas Pharma
- AstraZeneca
- AtlasXomics
- Australian Genome Research Facility
- Avance Biosciences
- Avectas
- Avellino Labs
- Avera Health
- Avita Therapeutics
- Axcelead Drug Discovery Partners
- Axxam
- Azenta Life Sciences
- Basepair
- BASF
- Battelle
- Bausch & Lomb
- Bayer
- Bayer CropScience
- Baylor College of Medicine
- Baylor Genetics
- BC Platforms
- Beam Therapeutics
- Beckman Coulter
- Becton Dickinson
- Beijing Genomics Institute (BGI)
- Ben-Gurion University
- Benson Hill Biosystems
- Berkeley Lights
- Berry Genomics
- Beth Israel Deaconess Medical Center
- BGI Americas
- BigOmics Analytics
- Bill and Melinda Gates Foundation
- Binx Health
- Bio-Medical Science
- Bio-Rad Laboratories
- Bio-Techne
- Bio.logis Genetic Information Management
- BioBam Bioinformatics
- BioBright
- BioCentriq
- Biocept
- Biodesix
- Biogen
- Bioheuris
- BioIntelliSense
- BioLegend
- BioLizard
- BioMap
- BioMarin Pharmaceutical
- Biomedical Advanced Research and Development Authority
- BiomX
- BioNano Genomics
- Bioneer
- Biosero
- Biosplice
- BioVectra
- Bioz
- bitBiome
- Blockchain Global
- Bluebee
- Bluebird Bio
- Blue Cross Blue Shield Association
- Blueprint Genetics
- BlueRock Therapeutics
- Boca Biolistics
- Boehringer Ingelheim
- Bone Therapeutics
- BostonGene
- Boston Scientific
- BRAIN Biotech
- BrainXell
- Breakthrough Genomics
- Brigham and Women's Hospital
- Bristol-Myers Squibb
- Broad Clinical Labs
- Broad Institute
- Broken String Biosciences
- Brooklyn ImmunoTherapeutics
- Buhler
- Burning Rock
- C2i Genomics
- C4X Discovery
- Cabaletta Bio
- California Institute for Regenerative Medicine
- Calyxt
- Cambridge Cancer Genomics
- CAMP4 Therapeutics
- Canadian Council
- CANbridge Pharmaceuticals
- Cancer Research Horizons
- Cancer Research UK
- Canopy Biosciences
- Capsida Biotherapeutics
- Caravan Biologix
- CARB-X
- CareDx
- Caribou Biosciences
- Caris Life Sciences
- Carlsmed
- Cartana
- Cartography Biosciences
- CasZyme
- Catalent
- Catamaran Bio
- Celemics
- Cell and Gene Therapy Catapult
- CellChorus
- Cellectis
- Cellgen Diagnostics
- Cellibre
- Cellistic
- Cell Microsystems
- Cell Mogrify
- Cellular Engineering Technologies
- Cellworks
- Celmatix
- Celsius Therapeutics
- Center for Aquaculture Technologies
- Center for Forensic Science Research & Education
- Centers for Disease Control and Prevention
- Centogene
- Central Institute for Experimental Animals
- Centre for Commercialization of Regenerative Medicine (CCRM)
- Centre for Research in Agricultural Genomics
- Centre Leon Berard
- Cepheid
- Cerba Research
- Cerner Enviza
- Certara
- CGA 369
- Champions Oncology
- CHAMPS Oncology
- Chan Zuckerberg Initiative
- Character Biosciences
- Charcot-Marie-Tooth Association
- Charite Universitatsmedizin Berlin
- CHDI Foundation
- Chiesi Farmaceutici
- Children's Hospital Boston
- Children's Hospital of Philadelphia
- Children's Medical Research Institute
- China Agricultural University
- Chinese Academy of Agricultural Science
- Chonnam National University
- Christian Doppler Research Association
- Chroma Medicine
- Chugai Pharmaceutical
- CHUM Research Centre
- CHU Sainte-Justine
- CIC nanoGUNE
- Cimeio Therapeutics
- Circuit Clinical
- City of Hope
- Clene Nanomedicine
- Cleveland Clinic
- Clover Therapeutics
- CMT Research Foundation
- Coastar Therapeutics
- COBO Technologies
- Code Ocean
- Codexis
- Codiak BioSciences
- Cofactor Genomics
- Colorado Center for Personalized Medicine
- Colors Farm
- Columbia University
- Columbia University Medical Center
- CombiGene
- Complete Genomics
- ConcertAI
- Concr
- Congenica
- Contextual Genomics
- COPD Foundation
- CoreBiome
- Coriell Life Sciences
- Corteva Agriscience
- Cosmo Bio
- CosmosID
- COTA
- Covaris
- CRISPR Therapeutics
- Crohn's and Colitis Foundation of America
- Crown Bioscience
- CSI Laboratories
- Culmination Bio
- Cumming
- CureMatch
- Curetis
- CureVac
- Curia
- Curio Genomics
- Cyclica
- Cyrus Biotechnology
- Cytobank
- CytoLynx Therapeutics
- Cytosurge
- CYTOVIA Therapeutics
- Cytox
- Daiichi Sankyo
- Dana-Farber Cancer Institute
- Dante Genomics
- Dante Labs
- Dartmouth-Hitchcock Medical Center
- DaRui Biotech
- Data Tecnica International
- Datavant
- DCx Biotherapeutics
- Decipher Biosciences
- Decode Health
- Dedalus Group
- Deep Genomics
- DefiniGEN
- Delix Therapeutics
- Demeetra AgBio
- Denali Therapeutics
- Dendreon
- Department of Defense
- Department of Health - Abu Dhabi
- Department of Veterans Affairs
- Desktop Genetics
- DestiNA Genomics
- Devyser Diagnostics
- Discovery Life Sciences
- Diversigen
- DNAnexus
- DNA Script
- Dolomite Bio
- Dovetail Genomics
- DrChrono
- Duke-NUS Graduate Medical School Singapore
- Duke University
- Duke University Health System
- DuPont
- DuPont Pioneer
- Dyadic International
- e-NIOS
- Eagle Genomics
- EchelonDx
- Edico Genome
- EdiGene
- Editas Medicine
- eGenesis
- Eisai
- Element Biosciences
- ElevateBio
- Elevation Oncology
- Eligo Bioscience
- Eli Lilly
- Elligo Health Research
- Elsevier
- EMBRAPA
- EMD Serono
- Emedgene
- EmendoBio
- Emendo Biotherapeutics
- Emory University
- EncrypGen
- Endocanna Health
- ENPICOM
- Ensoma
- Enzyvant Science
- Epic Sciences
- Epicypher
- Epilepsy Society
- Epivax
- Erasmus University Medical Center
- Erlangen University Hospital
- ERS Genomics
- Euformatics
- Eureka Eurostars
- Eurofins Scientific
- European Equity Partners
- European Molecular Genetics Quality Network
- European Organization for Research and Treatment of Cancer
- European Union
- Eversana
- Evidation Health
- EvidNet
- Evogene
- Evonetix
- Evotec
- Evvy
- Exact Sciences
- Expressive Neuroscience
- F1 Oncology
- Fabric Genomics
- Factor Bioscience
- Factorial Biotechnologies
- Factorial Diagnostics
- Falco
- FASMAC
- FatiAbGen
- FDNA
- Ferring Pharmaceuticals
- FinnGen
- First Genetics JCS
- Flare Therapeutics
- Flatiron Health
- Flow Pharma
- Fluent BioSciences
- Fluidigm
- Flywheel
- FMC
- Food and Drug Administration (FDA)
- Form Bio
- Fortis Life Sciences
- Foundation Fighting Blindness
- Foundation for Innovative New Diagnostics
- Foundation Medicine
- Fox Chase Cancer Center
- Francis Crick Institute
- Fred Hutchinson Cancer Research Center
- Freenome
- Friedreichs Ataxia Research Alliance
- Front Range Biosciences
- Fujifilm
- Fujifilm Diosynth Biotechnologies
- Fujitsu Laboratories
- Fulgent Genetics
- Fulgent Pharma
- Fusion Genomics
- FuturaGene
- G+FLAS Life Sciences
- G3 Therapeutics
- G42 Healthcare
- Galatea Bio
- Ganymede Bio
- GC Genome
- GDM Seeds
- GEDmatch
- GE Healthcare
- Geisel School of Medicine at Dartmouth
- Gemini Therapeutics
- GEMoaB
- GenAhead Bio
- Gencove
- Gene by Gene
- GeneCentric Therapeutics
- Genective
- GenEdit
- GeneDX
- GenEmbryomics
- Genentech
- General Genomics
- Geneseeq
- GeneThera
- Genetica
- Genetic Technologies
- Genetiks
- Genetron Health
- Genevant Sciences
- Genewiz
- Geneyx
- Genialis
- GenKOre
- Genolution
- Genome BC
- Genome Canada
- GenomeDx
- Genome Insight
- Genome Medical
- Genomenon
- Genome Prairie
- Genomic Biopharma
- Genomics
- Genomics England
- Genomic Testing Cooperative
- Genomic Vision
- Genomill Health
- Genomind
- Genomoncology
- Genoox
- GenoScreen
- Genosity
- genOway
- GenScript Biotech
- Genspace
- Gensus
- Genuity Science
- GenXys
- Genzeva
- Georgetown University
- German Cancer Research Center
- Gilead Sciences
- Ginkgo BioWorks
- Global Genes
- Global Genomics Group
- Glooko
- Goethe University Frankfurt
- Government of Canada
- Great Ormond Street Hospital (GOSH)
- Greenlight Biosciences
- Gretel
- GRYT Health
- GSK
- GSK Consumer Healthcare
- Guardant Health
- Gusto Global
- H3 Biomedicine
- Hackensack Meridian Health
- Hamilton Company
- Hamilton Robotics
- Hanmi Pharmaceutical
- Hannover Medical School
- HaploX
- Harpe Bioherbicide Solutions
- Harvard Medical School
- Harvard University
- HealthSteps
- HebeCell
- Heligenics
- Helix
- Helmholtz Zentrum Munchen
- Henan Cancer Hospital
- Henry Ford Health System
- HepaTx
- Hereditary Neuropathy Foundation
- Hillstream BioPharma
- Hitachi High-Technologies Corporation
- Holmusk
- Horizon Discovery
- Hospital for Sick Children
- Hospital for Special Surgery
- HTG Molecular Diagnostics
- Hudson-Alpha Institute for Biotechnology
- HuidaGene Therapeutics
- Humacyte
- Human Cell Atlas
- Humanigen
- Hummingbird Bioscience
- Hunterian Medicine
- IBM
- IBM Watson Health
- Icahn School of Medicine at Mount Sinai
- ICAN
- IDbyDNA
- IDEAYA Biosciences
- ID Solutions
- iECURE
- Illumina
- ILUM Health Solutions
- IMBdx
- Immatics Biotechnologies
- Immunai
- Immunex
- ImmunoChina Pharmaceuticals
- Immusoft
- Implant Therapeutics
- IncellDx
- Incyte
- Indiana University
- Indivumed
- IndyGeneUS AI
- InfoChem
- Inivata
- InnoBation
- Innoplexus
- Innovate UK
- Innovative Genomics Initiative (IGI)
- Inocras
- Inovio Pharmaceuticals
- Inscripta
- Inserm
- Insitro
- InSphero
- Inspirata
- Institut Gustave Roussy
- Institut Imagine
- Insulet
- Integra
- Integra Biosciences
- Integrated Biosciences
- Integrated DNA Technologies
- Integra Therapeutics
- Intel
- Intellia Therapeutics
- Intelligence Advanced Research Projects Activity (IARPA)
- Intelliseq
- Interface People
- Intermountain Precision Genomics
- International Center for Genetic Engineering and Biotechnology
- International Myeloma Foundation
- International Niemann-Pick Disease Registry
- International Rice Research Institute
- International Spine Study Group Foundation
- InterSystems
- inviCRO
- Invitae
- InVivoScribe
- Ionis Pharmaceuticals
- Iovance Biotherapeutics
- IQVIA
- IRBM
- iReceptor Plus
- Israeli National Authority for Technological Innovation
- Jackson Laboratory
- Janssen Biotech
- Janssen Pharmaceuticals
- Janssen Pharmaceutica NV
- Janssen Research & Development
- Japan SLC
- JASE Health
- JCR Pharmaceuticals
- Jeffrey Modell Foundation
- Johns Hopkins University
- John Snow
- Johnson & Johnson Innovation
- Jorna Therapeutics
- Jumpcode Genomics
- Kadimastem
- Kamau Therapeutics
- Kantonsspital St. Gallen
- Kapoose Creek Bio
- Kartos Therapeutics
- Keck Graduate Institute of Applied Life Sciences
- KEW
- Keygene
- King Abdullah International Research Center
- KingMed Diagnostics
- Kiromic Biopharma
- Kite Pharma
- KOMO Biosciences
- Komodo Health
- Konica Minolta Precision Medicine
- KPMG
- KromaTiD
- KSQ Therapeutics
- Kura Oncology
- Kytopen
- Kyverna Therapeutics
- Laboratorio Curie
- Laboratory Corporation of America
- La Jolla Institute for Allergy & Immunology
- Lantern Pharma
- Latvian Institute of Organic Synthesis
- Lee Moffitt Cancer Center
- Lenovo
- Lepton Pharmaceuticals
- Lesaffre
- Les Laboratoires Servier
- Leveragen
- Lexent Bio
- LGC
- Life Edit Therapeutics
- LifeLabs Medical Laboratory Services
- LifeMap Sciences
- LifeOmic
- Life Raft Group
- Linus Biotechnology
- LMU University Hospital Munich
- Locus Biosciences
- LogicBio Therapeutics
- LogicInk
- Logomix
- Longenesis
- Lonza
- Loxo Oncology
- Ludwig Institute for Cancer Research
- Lunaphore
- Lung Cancer Research Foundation
- M2Gen
- M42
- Macrogen
- Mainz Biomed
- Mammoth Biosciences
- Mandos
- Manifold AI
- MapKure
- Massachusetts General Hospital
- Massachusetts Institute of Technology
- Mass General Brigham
- Massive Bio
- Maxcyte
- Mayo Clinic
- MC10
- MD Anderson Cancer Center
- Medaffcon
- Medgenics
- MedGenome
- Medical College of Wisconsin
- Medical University of Graz
- Medicinal Genomics
- Medicines Discovery Catapult
- MEDiC Life Sciences
- Medicom
- MedStar Health Research Institute (MHRI)
- Meharry Medical College
- Meiogenix
- Mekonos
- Melax Technologies
- Memorial Sloan Kettering Cancer Center
- Menarini Silicon Biosystems
- Merck and Co
- Merck KGaA
- Merus
- Metabolon
- Metagenomi
- MGI Pharma
- MGI Tech
- Michael J Fox Foundation
- Michelson Center
- Microba Life Sciences
- Microbiotica
- MicroGenDX
- MicroMGx
- Micronoma
- Microsoft
- MiLaboratories
- MilliporeSigma
- Miltenyi Biotec
- MindImmune Therapeutics
- Mind Medicine
- Mirador Therapeutics
- Miroculus
- Mirus Bio
- Mission Bio
- Modalis Therapeutics
- Moderna
- Molbio Diagnostics
- Molecular Health
- Molecular Templates
- Moleculera Labs
- Monoceros Biosystems
- Monsanto
- Moonlight Bio
- MORE Health
- MorphoSys
- Moss Genomics
- MP Group
- Multiplex Genomics
- Muna Therapeutics
- Muscular Dystrophy Association
- myDNA
- Myeloid Therapeutics
- myNEO
- Myriad Genetics
- Myrtelle
- MyVytalics
- NABsys
- Nalagenetics
- Namocell
- Nanite
- Nankai Hospital
- NanoCellect Biomedica
- NanoString Technologies
- Nashville Biosciences
- Natera
- National Cancer Center
- National Cancer Center of Japan
- National Cancer Centre Singapore
- National Cancer Institute
- National Center for Tumor Diseases
- National Health Service
- National Human Genome Research Institute
- National Institute of Allergy and Infectious Diseases
- National Institute of Child Health and Human Development
- National Institute of General Medical Sciences
- National Institutes of Health
- National Kidney Foundation
- National Organization for Rare Disorders
- Navican
- Ncardia
- Nebraska Medicine
- Nebula Genomics
- NEC
- Negen
- Neo7Bioscience
- Neochromosome
- Neogen
- Neogenomics
- NeraCare
- Netherlands Cancer Institute
- NetraMark
- Neuron23
- New England Biolabs
- NewStem
- New York Genome Center (NYGC)
- New York State Department of Health
- New York University School of Medicine
- Next Gen Diagnostics
- Next Generation Manufacturing Canada
- NGeneBio
- Nippon Gene
- Nkarta Therapeutics
- NLS Pharmaceutics
- NMI Natural and Medical Sciences Institute
- Nonacus
- Normunity
- Northern RNA
- North Med
- Northwell Health
- Novartis
- Novaseek Research
- Novellus Biopharma
- NovellusDx
- Novellus Therapeutics
- Novigenix
- Novogene
- Novome Biotechnologies
- Novo Nordisk
- Nrgene
- Nucleix
- NuProbe
- Nuvisan Pharma Services
- Nvidia
- NYU Grossman School of Medicine for Preclinical and Clinical Research
- Obsidian Therapeutics
- ObvioHealth
- Ochre Bio
- Octant
- Ohio State University
- Olink Bioscience
- OMAPiX
- Omico
- OmniaBio
- Omniome
- OncoCyte
- OncoDNA
- OncoImmunity
- OncologyInformationService
- Oncology Research Information Exchange Network
- Oncompass Medicine
- Oncoshot
- OncXerna Therapeutics
- One Biosciences
- One Codex
- ONK Therapeutics
- Ono Pharmaceutical
- Onramp Bioinformatics
- Ontada
- Ontario Institute for Cancer Research
- OpenBench
- OpenEye Scientific Software
- Open Medicine Institute
- Open Source Imaging Consortium
- Opentrons Labworks
- OpGen
- Optibrium
- OptraSCAN
- Orchid Cellmark
- Oregon Health Sciences University
- OrigiMed
- Origin Agritech
- Orna Therapeutics
- Orum Therapeutics
- Oryzon
- OSE Immunotherapeutics
- Otsuka
- Ovation
- Owkin
- Oxford Biodynamics
- Oxford Gene Technology
- Oxford Genetics
- Oxford Nanopore Technologies
- Ozette Technologies
- Pacific Biosciences
- Paige
- Pairwise Plants
- Palisade Bio
- Pancreatic Cancer Action Network
- Pancreatic Cancer Collective
- Pancreatic Cancer Early Detection Consortium
- Paragon Genomics
- Parent Project Muscular Dystrophy
- Parexel
- Parse Biosciences
- Partek
- Path BioAnalytics
- PathGroup
- Pathway Solutions
- Pennsylvania State University
- PerkinElmer
- Personal Genome Diagnostics
- Personalis
- PetaGene
- Pfizer
- Pharmanest
- Pharnext
- Phase Genomics
- PhenoVista Biosciences
- Pierian
- PierianDx
- Pillar Biosciences
- Pioneer Hi-Bred
- PlantArcBio
- PlumCare
- Pluristem Therapeutics
- Pluristyx
- PPD
- Precision BioSciences
- Precision NanoSystems
- Predicine
- Predictive Oncology
- Premier Inc
- Prenetics
- Prepaire Labs
- Prescient Medical
- Prevail Therapeutics
- Prime Medicine
- Princess Margaret Hospital
- ProBioGen
- Progenesis
- Progknowse
- Project 8p Foundation
- Promega
- Prometheus Biosciences
- Pro Pharmaceuticals
- Prophase Labs
- Protagen
- Proteic Bioscience
- ProteoMediX
- Proteona
- Proteus Genomics
- Proton Therapy
- Pryzm Health
- Q2 Solutions
- Qatar Foundation
- QIAGEN
- Qihan Biotech
- Quanterix
- QuantHealth
- QuantumDx
- Quest Diagnostics
- rAAVen Therapeutics
- Radboud University Nijmegen Medical Centre
- Rady Children's Institute for Genomic Medicine
- RARE-X
- Realm IDx
- ReCode Therapeutics
- Recombia Biosciences
- Recursion
- Regeneron Genetics Center
- Regeneron Pharmaceuticals
- ReNAgade Therapeutics
- Repare Therapeutics
- Repertoire Genesis
- Replicate Bioscience
- Resilient Biotics
- Resolve Biosciences
- Reveal Genomics
- RevolKa
- Revvity
- Rice University
- Ricoh
- RIKEN Center for Integrative Medical Sciences
- RIKEN Research Institute
- Ripe Technology
- Roche
- Roche Diagnostics
- Roivant Sciences
- Rokline Health Concepts
- Rosetta Biosciences
- Royal Philips Electronics
- RTI International
- Rutgers University
- RxGenomix
- Ryailti
- Rznomics
- S2 Genomics
- Saama
- Saint Louis University
- SalioGen Therapeutics
- Sana Biotechnology
- Sangamo Therapeutics
- Sanofi
- Santa Cruz Biotechnology
- Saol Therapeutics
- Saphetor
- Sapio Sciences
- Sarepta Therapeutics
- Savana
- Scale Biosciences
- Scarab Genomics
- Sciex
- Scilligence
- Scipher Medicine
- SCM Pharma
- Scribe Therapeutics
- Scripps Translational Science Institute
- Seattle Childrens Research Institute
- Secarna Pharmaceuticals
- SeekIn
- Self Care Catalysts
- Sema4
- Sensyne Health
- Sentieon
- SenzaGen
- Seoul National University
- Seqster
- Sequentify
- SeQure Dx
- SeqWell
- Seracare Life Sciences
- Serokell
- Serotiny
- Setsuro Tech
- Seven Bridges Genomics
- Shanghai ChemPartner
- Shape Therapeutics
- Shenzhen Salubris Pharmaceuticals
- Sherlock Biosciences
- Shionogi
- Shivom
- Shoreline Biosciences
- Sigma-Aldrich
- Simons Searchlight
- Singleron Biotechnologies
- Singular Genomics Systems
- SiSaf
- Sohm
- Solvay
- SomaLogic
- SOPHiA Genetics
- Spanish National Cancer Research Centre
- SparingVision
- Spatial Genomics
- Spectrum Pharmaceuticals
- Sphere Fluidics
- Sphere Health
- SPT Labtech
- St. Lukes Health System Clinically Integrated Providers
- Stanford University
- Stanford University School of Medicine
- Stem Genomics
- Stem Pharm
- StemSight
- Stockholm University
- Strand Life Sciences
- Strata Oncology
- Streck Laboratories
- Structural Genomics Consortium
- Sumitomo Dainippon Pharma
- Sumitomo Pharmaceuticals
- Sumitovant Biopharma
- Summit Pharmaceuticals
- Sunnybrook Research Institute
- SunTerra Biotechnology
- Susan G. Komen for the Cure
- Swift Biosciences
- Swiss Institute of Bioinformatics (SIB)
- Swiss Rockets
- Syapse
- Synbal
- Syngene International
- Syngenta
- Syngulon
- Synthego
- Syros Pharmaceuticals
- Sysmex
- Sysmex Inostics
- Taconic Biosciences
- Tagomics
- Taiwan Precision Medicine Initiative
- Takara Bio
- Takara Bio USA
- Takeda Pharmaceutical
- Takeda Ventures
- Tango Therapeutics
- TargetGene Biotechnologies
- Tavros Therapeutics
- Taysha Gene Therapies
- TCR2 Therapeutics
- Tecan
- Telesis Bio
- Tempus
- Tesis Biosciences
- Tessera Therapeutics
- TetraScience
- Texas Oncology
- The Human Protein Atlas
- The New York Stem Cell Foundation
- The Parker Institute For Cancer Immunotherapy
- Theragent
- Theraly Fibrosis
- TheraPanacea
- Thermo Fisher Scientific
- The Silverstein Foundation for Parkinson's
- Thomas Jefferson University
- Tokyo Medical and Dental University
- Tolo Biotech
- Toolgen
- Tow Foundation
- TP Therapeutics
- Tracer Biotechnologies
- Trajan Scientific and Medical
- TransCode Therapeutics
- Transgene
- Translational Drug Development
- Translational Genomics Research Institute
- Translational Software
- Transnetyx
- Transomic Technologies
- TriNetX
- Trinity Biotech
- Tropic Biosciences
- Truveta
- TwinStrand Biosciences
- Twinstrand Therapeutics
- Twist Bioscience
- Ultima Genomics
- Ultivue
- Umoja Biopharma
- Undisclosed Company
- Univeristy of Durham
- Universal Cells
- University College London
- University Health Network
- University Hospital Heidelberg
- University of Adelaide
- University of Alabama at Birmingham
- University of Arkansas
- University of British Columbia
- University of Buffalo
- University of California
- Davis
- University of California
- San Diego
- University of California Berkeley
- University of California Irvine
- University of California Los Angeles
- University of California San Francisco
- University of California Santa Cruz
- University of Colorado
- University of Colorado Denver
- University of Edinburgh
- University of Florida
- University of Glasgow
- University of Greifswald
- University of Hong Kong
- University of Illinois
- University of Illinois Urbana-Champaign
- University of Kansas
- University of Lausanne
- University of Manchester
- University of Massachusetts
- University of Massachusetts Medical School
- University of Miami
- University of Minnesota
- University of Montreal
- University of Nebraska
- University of Ottowa
- University of Oxford
- University of Pennsylvania
- University of Pittsburgh
- University of Rennes
- University of Rochester Medical Center
- University of Rostock
- University of Sydney
- University of Texas
- University of Tokyo
- University of Tubingen
- University of Utah
- University of Vermont
- University of Verona
- University of Washington
- University of Wisconsin
- University of Wisconsin-Madison
- University of Wisconsin Carbone Cancer Center (UWCCC)
- UpToDate
- US Department of Agriculture
- US Oncology
- Valo Health
- Variant Bio
- Veracyte
- Verana Health
- Verge Genomics
- Veritas
- Veritas Genetics
- Verogen
- Vertex Pharmaceuticals
- Verve Therapeutics
- Vesigen Therapeutics
- Viatris
- VIB
- Victoria University
- VieCure
- ViennaLab Diagnostics
- Vir Biotechnology
- Virginia Commonwealth University
- Vitaccess
- Vita Therapeutics
- Vithas Group
- ViVerita Therapeutics
- Vivlion
- Vizgen
- Volta Labs
- Vor Biopharma
- Wake Forest University
- Wasatch BioLabs
- Washington University in St Louis
- Watchmaker Genomics
- Weihai Weigao Medical Devices
- Weill Cornell Medical College
- Wellcome Trust
- Wellcome Trust Sanger Institute
- Western Digital
- Whitehead Institute
- Willow Biosciences
- WuXi NextCODE Genomics
- Xcell Biosciences
- Xencor
- Xpress Technologies
- Yale School of Medicine
- Yale University
- Yeda Research and Development Company
- Yield10 Bioscience
- YolTech Therapeutics
- ZAI Laboratory
- ZeClinics
- Zephyr AI
- Zoetis
- Zymergen
- Zymo Research
Methodology
- The publisher reports provide insight into the trends and terms of partnering deals in the global life sciences sector.
- The publisher reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.
- The publisher analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.
- The publisher reports source deal data from our proprietary deals and alliances database. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal.
- The data in the deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.
The publisher provides comprehensive coverage of the following partnering or deal types:
- Asset purchase
- Assignment
- Co-development
- Co-market
- Co-promotion
- Collaborative R&D
- Contract service
- CRADA
- Cross-licensing
- Development
- Distribution
- Equity purchase
- Evaluation
- Grant
- Joint venture
- Licensing
- Loan
- Manufacturing
- Marketing
- Option
- Promotion
- Research
- Royalty financing
- Settlement
- Spin out
- Sub license
- Supply
- Termination
- Warrant
Every deal record is fully categorized and includes the following data, where available:
- Industry sector
- Therapy areas
- Technology type
- Deal components
- Financial terms
- Stage of development
- Exclusivity
- Asset type
- Geographic focus
- Excluded geography
- Company press release
- SEC filing data including contract document
All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.
LOADING...
